Gan & Lee Pharmaceuticals Co., Ltd.SSE: 603087

Announcement on Implementation of Dividend Distribution for 2025

May 25, 2026 · Issued by Gan & Lee Pharmaceuticals Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · May 25, 2026 · 4 pages · Chinese

On 6ix: 6ix.com/news/announcement-on-implementation-of-dividend-distribution-for-2025-339

Release

Announcement on Implementation of Dividend Distribution for 2025

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Gan & Lee Pharmaceuticals Co., Ltd. on 6ix

Earlier from Gan & Lee Pharmaceuticals

Announcement on Obtaining of European Commission Marketing Authorization for Insulin Lispro InjectionMay 15
Announcement on Resolutions of the 2025 Annual General MeetingMay 14
Announcement on Obtaining of European Commission Marketing Authorization for Aspart InjectionMay 7
Announcement on Completion of Administration of the First Subject in Phase III Clinical Trial of New Indication of Bofanglutide (GZR18) InjectionApr 24
Notice on Convening the 2025 Annual General MeetingApr 23

Later from Gan & Lee Pharmaceuticals

Announcement on Sterile Preparations Passing ANVISA GMP CertificationMay 27
Announcement on Release of Pledge of Partial Shares Held by Shareholders with Over 5% SharesJun 3
Notice on Convening the 1st Extraordinary General Meeting in 2026Jun 11
Indicative Announcement on Unlocking of the 3rd Sales Restriction Lifting Period under the 2022 Restricted Stock Incentive Plan and Unlocking and Listing of the 2nd Sales Restriction Lifting Period under the 2024 Restricted Stock Incentive PlanJun 12
Gan & Lee Pharmaceuticals Achieves Significant Progress in Its Dual Pipeline for Metabolic Diseases -- Weekly Insulin Ludefen (GZR4) Meets Primary Endpoint in Phase III Clinical Trial in China; Bofanglutide Meets Primary Endpoints in Phase III Weight Loss Study in China and Phase II Study in the U.S.Jun 12

All Gan & Lee Pharmaceuticals news releases

Follow Gan & Lee Pharmaceuticals into a list and get an email when it puts out news.

Follow Gan & Lee Pharmaceuticals